Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Tezacaftor and ivacaftor for cystic fibrosis homozygous or heterozygous for F508del mutation in patients aged 12 years and older who discontinued treatment with Orkambi	Ivacaftor (Kalydeco; VX-770) , Symkevi (fixed dose combination: Tezacaftor; Ivacaftor)	Cystic fibrosis	Genetic Disorders , Respiratory System	2019	View \| Download
Teprotumumab for thyroid eye disease	Teprotumumab ((HZN-001; R-1507; RV 001)	Thyroid eye disease (TED)	Immunology	2024	View \| Download
Tepotinib for advanced non-small cell lung cancer harbouring MET exon14- skipping mutations	Tepotinib (MSC-2156119J; TEPMETKO)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2020	View \| Download
Teplizumab for the delay of clinical type-1 diabetes in at-risk patients aged 8 years and over	Teplizumab (PRV-031; MGA031)	Type 1 diabetes	Endocrine Nutritional and Metabolic Disorders	2022	View \| Download
Tenecteplase for treating acute ischaemic stroke	Tenecteplase	Acute ischaemic stroke	Cardiovascular System	2023	View \| Download
Tendoncel for the treatment of tennis elbow	Tendoncel	Tendon injury	Musculoskeletal System	2017	View \| Download
Tenapanor for Irritable Bowel Syndrome with Constipation	Tenapanor (AZD1722; RDX5791; Ibsrela)	Irritable bowel syndrome with predominant constipation (IBS-C)	Gastroenterology	2018	View \| Download
Telmisartan-amlodipine-indapamide for treating hypertension	Telmisartan-Amlodipine-Indapamide (GMRx2)	Hypertension	Cardiovascular System	2024	View \| Download
Telisotuzumab vedotin for previously treated c-MET overexpressing EGFR wild-type non-squamous non-small cell lung cancer	Telisotuzumab vedotin (ABBV-399;ABBV 399;ABBV399;ABT-399;Teliso-V)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Teduglutide for short bowel syndrome in infants	Teduglutide	Short bowel syndrome	Gastroenterology	2022	View \| Download